Genome-wide association study of susceptibility to idiopathic pulmonary fibrosis

…, LM Kraven, M Obeidat, X Li, M Ng… - American journal of …, 2020 - atsjournals.org
Rationale: Idiopathic pulmonary fibrosis (IPF) is a complex lung disease characterized by
scarring of the lung that is believed to result from an atypical response to injury of the …

Outcomes following trauma laparotomy for hypotensive trauma patients: a UK military and civilian perspective

…, IM Smith, JG Penn-Barwell, LM Kraven… - Journal of Trauma …, 2018 - journals.lww.com
BACKGROUND The management of trauma patients has changed radically in the last
decade, and studies have shown overall improvements in survival. However, reduction in …

[HTML][HTML] Shared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severity

J Fadista, LM Kraven, J Karjalainen, SJ Andrews… - …, 2021 - thelancet.com
Background Idiopathic pulmonary fibrosis (IPF) is a complex lung disease, characterized by
progressive lung scarring. Severe COVID-19 is associated with substantial pneumonitis and …

Genetic overlap between idiopathic pulmonary fibrosis and COVID-19

…, B Guillen-Guio, E Croot, LM Kraven… - European …, 2022 - Eur Respiratory Soc
Coronavirus disease 2019 (COVID-19) is an infectious disease potentially leading to long-lasting
respiratory symptoms and has resulted in over 4 million deaths worldwide. Idiopathic …

[HTML][HTML] Forced vital capacity trajectories in patients with idiopathic pulmonary fibrosis: a secondary analysis of a multicentre, prospective, observational cohort

…, PL Molyneaux, RJ Allen, LM Kraven… - The Lancet Digital …, 2022 - thelancet.com
Background Idiopathic pulmonary fibrosis is a progressive fibrotic lung disease with a
variable clinical trajectory. Decline in forced vital capacity (FVC) is the main indicator of …

Cluster analysis of transcriptomic datasets to identify endotypes of idiopathic pulmonary fibrosis

LM Kraven, AR Taylor, PL Molyneaux, TM Maher… - Thorax, 2023 - thorax.bmj.com
Background Considerable clinical heterogeneity in idiopathic pulmonary fibrosis (IPF) suggests
the existence of multiple disease endotypes. Identifying these endotypes would improve …

[HTML][HTML] Mapping brain endophenotypes associated with idiopathic pulmonary fibrosis genetic risk

AR Mohammadi-Nejad, RJ Allen, LM Kraven… - …, 2022 - thelancet.com
Background Idiopathic pulmonary fibrosis (IPF) is a serious disease of the lung parenchyma.
It has a known polygenetic risk, with at least seventeen regions of the genome implicated to …

P32 Using genetic information to define idiopathic pulmonary fibrosis in UK biobank

OC Leavy, RJ Allen, LM Kraven, AD Morgan, MD Tobin… - 2022 - thorax.bmj.com
Introduction Idiopathic pulmonary fibrosis (IPF) is a complex, heterogeneous fibrotic lung
disease with median survival of 3 years. IPF can be defined in population studies, such as UK …

Understanding the genetic basis of disease endotypes in idiopathic pulmonary fibrosis

LM Kraven - 2023 - figshare.le.ac.uk
Idiopathic pulmonary fibrosis (IPF) is a rare, incurable disease of unknown cause characterised
by progressive scarring of the lungs. The prognosis of IPF is poor with a median survival …

Shared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severity (preprint)

J Fadista, LM Kraven, J Karjalainen, SJ Andrews… - 2020 - pesquisa.bvsalud.org
BackgroundIdiopathic pulmonary fibrosis (IPF) is a complex lung disease, characterized by
progressive lung scarring. Severe COVID-19 is associated with substantial pneumonitis and …